Ace inhibitors and erythropoietin response in hemodialysis patients

American Journal of Kidney Diseases

Volumn 36, Issue 4, 2000, Pages 880-

  Erturk, S ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS; DRUG EFFICACY; HEMATOCRIT; HEMODIALYSIS; HUMAN; HYPERTENSION; LETTER; TREATMENT OUTCOME;

EID: 0033820720     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.19207     Document Type: Article

References (3)

1. ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients
2. The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients
3. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients